Approximately 60 surgical procedures referred through the Welsh Gender Service (WGS) have been cancelled this year following a pause on referrals initiated in August, according to Wales' health minister. The decision came after NHS officials raised concerns about whether patients identifying as transgender had undergone appropriate clinical assessment before being referred for surgery.
This marks the first occasion that specific figures have been disclosed regarding the number of individuals affected by the referral pause. The announcement was made during a Senedd debate where lawmakers from multiple parties expressed differing views on the decision.
What prompted the pause?
The NHS Wales Joint Commissioning Committee's Quality, Safety and Outcomes Committee escalated the service to Level 3 on 24 August 2026, triggering the suspension of surgical referrals. According to NHS Wales, concerns were raised about the proportion of Welsh patients progressing to surgery compared with England, and about how referrals had been assessed.
The committee identified several clinical issues. In some cases, patients did not meet the basic requirements for surgery, with an unsuitable body mass index (BMI) cited as one contributing factor. The data showed that the proportion of Welsh patients advancing from referral for certain surgical procedures was significantly lower than rates across the border in England, while simultaneously the rate of surgery referrals itself was significantly higher.
Some patients discovered their surgery cancellations while already in hospital, a revelation that prompted widespread concern about the handling of the pause.
How are patients responding?
Welsh Green leader Anthony Slaughter described the situation as creating an
unbearable limbofor those affected. He told Members of the Senedd that some patients felt
abandoned, alone and confused, having had the rug pulled from under them, noting that
they had jumped through every hoop asked of them, had arranged and rearranged their lives around this day.
Slaughter called for a review of what he termed the governance failure that left both patients and government blindsided, and urged the implementation of robust accountability measures for the commissioning committee. He was supported by Plaid Cymru MS Matthew Jones, who accused the committee of failing to publicly or adequately explain its concerns.
Reform MS Cristiana Emsley acknowledged that while the pause might cause distress and patients must be supported, she argued that
what would be unacceptable is continuing irreversible referrals when serious concerns exist about referral appropriateness, clinical governance and patient safeguards.
Conservative health spokesperson Natasha Asghar defended the pause, stating that pausing irreversible surgery while serious concerns are investigated is an appropriate precautionary measure.
What support is available during the pause?
Health Minister Mabon ap Gwynfor stated his commitment to bringing
certaintyto affected patients as quickly as possible. Cardiff and Vale University Health Board said the pause applied only to the surgical pathway and that hormone therapy support, endocrine review and psychological support services continued.
The health minister emphasised that he expected all patients impacted by the pause to have access to necessary support while the review was undertaken. He also made clear to the commissioning committee that the urgent clinical review needed to be swift to minimise disruption and distress for those on the waiting list.
What is the review process?
The NHS Wales Joint Commissioning Committee has commissioned a clinical review to examine whether the 60 cancelled surgeries can proceed before the end of the year. NHS Wales said the review would examine whether aspects of the assessment process before referral had been completed appropriately.
According to the committee's statement, the review will prioritise those individuals who are further along the pathway to allow appropriate referrals to proceed as soon as possible. The committee identified that approximately 60 patients were due for surgery between the pause in August and the end of December, and expressed confidence that all 60 cases could be reviewed before the end of December.
The review will start with patients whose planned surgery dates were earliest and continue in date order. Experienced gender clinicians will undertake the work, and NHS Wales has sought confirmation from NHS England surgical providers that patients able to proceed with surgery will be prioritised.
Patients waiting for surgery in 2027 and those awaiting surgical assessment will also have their referrals reviewed to confirm that the requirements for surgery have been met.
The committee stated it had not identified any patients who had come to harm, but said concerns were raised through complaints, correspondence and other information.
What happens next?
NHS Wales said appointments to the independent clinical review panel had been made and the review was expected to begin in the week commencing 21 September. Cardiff and Vale University Health Board said initial findings from the Welsh Gender Service review were expected by the end of 2026.
A wider independent review into the service is also taking place, with findings expected later in the year. Individual cases will be reviewed and patients will proceed to surgery once appropriate clinical assurances are in place.
Key Facts
- Approximately 60 surgeries referred through the Welsh Gender Service have been cancelled following an August pause on referrals
- The pause was triggered by concerns about whether patients had undergone appropriate clinical assessment, with issues including unsuitable BMI and questions about assessment processes
- The Welsh Gender Service provides referrals for adult patients living in Wales, but all NHS surgeries are carried out in England
- An independent clinical review is expected to begin in late September 2026, with initial findings due by the end of the year
- Support services including hormone therapy, endocrine review and psychological support continue during the surgical pathway pause
